Changes in cytokines and aggrecan ARGS neoepitope in synovial fluid and serum and in C‐terminal crosslinking telopeptide of type II collagen and N‐terminal …
A Struglics, S Larsson, N Kumahashi… - Arthritis & …, 2015 - Wiley Online Library
Objective To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal …
A Struglics, S Larsson… - Arthritis & …, 2015 - portal.findresearcher.sdu.dk
OBJECTIVE: To prospectively monitor levels of proinflammatory cytokines and aggrecan
ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C‐Terminal Crosslinking Telopeptide of Type II Collagen and N‐Terminal …
A Struglics, S Larsson, N Kumahashi, R Frobell… - Arthritis & …, 2015 - infona.pl
Objective To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal …
A Struglics, S Larsson, N Kumahashi, R Frobell… - 2015 - hero.epa.gov
OBJECTIVE: To prospectively monitor levels of proinflammatory cytokines and aggrecan
ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
ARGS neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal …
A Struglics, S Larsson, N Kumahashi… - Arthritis & …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS
neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C-Terminal Crosslinking Telopeptide of Type II Collagen and N-Terminal …
A Struglics, S Larsson, N Kumahashi… - Arthritis & …, 2015 - europepmc.org
Objective To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS
neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
neoepitope in synovial fluid and serum as well as levels of C-terminal crosslinking …
Changes in Cytokines and Aggrecan ARGS Neoepitope in Synovial Fluid and Serum and in C‐Terminal Crosslinking Telopeptide of Type II Collagen and N‐Terminal …
A Struglics, S Larsson, N Kumahashi… - Arthritis & …, 2015 - Wiley Online Library
Objective To prospectively monitor levels of proinflammatory cytokines and aggrecan ARGS
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …
neoepitope in synovial fluid and serum as well as levels of C‐terminal crosslinking …